Project description:Development of a cost-effective and practical targeted transcriptional fingerprinting assay (TFA) for monitoring a diverse repertoire of immune responses identified in the human blood transcriptome relying on a modular transcriptional repertoire built on the basis of variations in transcript abundance measured on a genome wide scale in the blood of nearly 1000 subjects across 16 immunologic conditions.

2020-06-16 | GSE100156 | GEO

Multicentric dermatofibrosarcoma protuberans in patients with adenosine deaminase-deficient severe combined immune deficiency.

Project description: Not available

| S-EPMC3294021 | biostudies-literature

Long-term outcomes after gene therapy for adenosine deaminase severe combined immune deficiency.

Project description: Not available

| S-EPMC8525336 | biostudies-literature

The diagnosis of severe combined immunodeficiency (SCID): The Primary Immune Deficiency Treatment Consortium (PIDTC) 2022 Definitions.

Project description: Not available

| S-EPMC9905311 | biostudies-literature

Adenosine Deaminase (ADA)-Deficient Severe Combined Immune Deficiency (SCID) in the US Immunodeficiency Network (USIDNet) Registry.

Project description: Not available